Literature DB >> 5004175

Immunological properties of neoplastic neural tissues.

H R Wickremesinghe, P O Yates.   

Abstract

The results are presented of the examination of 28 neoplasms from the nervous system for an organ-specific antigenic material demonstrated in glial cells and myelin, using gel diffusion, immunocytotoxicity and immunofluorescence techniques.The antigenic material was demonstrable in benign gliomas and in those of low-grade malignancy, but not in the more malignant gliomas and non-gliomatous neoplasia.The implications of the loss of specific antigenic material with reference to cell structure and function, and some fallacies in the interpretation of the significance of tissue specific antigen in carcinogenesis are discussed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5004175      PMCID: PMC2008866          DOI: 10.1038/bjc.1971.86

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  A CRYOSTAT METHOD FOR THE EXTRACTION OF SOLUBLE TISSUE COMPONENTS.

Authors:  E H TEE; M WANG; J WATKINS
Journal:  Nature       Date:  1964-11-14       Impact factor: 49.962

2.  Lack of staining of testicular tumors by anti-sperm and anti-testis antibodies.

Authors:  R HIRAMOTO; J JURAND; J BERNECKY; D PRESSMAN
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

3.  Immunohistochemical staining properties of the N-2-FAA rat hepatoma.

Authors:  R HIRAMOTO; J BERNECKY; J JURANDOWSKI; D PRESSMAN
Journal:  Cancer Res       Date:  1961-11       Impact factor: 12.701

4.  Unspecific interactions between serum and tissue sections in the fluorescent-antibody technic for tracing antigens in tissues.

Authors:  H MAYERSBACH
Journal:  J Histochem Cytochem       Date:  1959-11       Impact factor: 2.479

5.  Immunological differences between normal and malignant cells.

Authors:  R C NAIRN; H G RICHMOND; M G McENTEGART; J E FOTHERGILL
Journal:  Br Med J       Date:  1960-11-05

6.  Distribution of tissue-specific antigens in centrifugal fractions of rat liver.

Authors:  P VOGT
Journal:  Nature       Date:  1958-12-27       Impact factor: 49.962

7.  Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro.

Authors:  T H WELLER; A H COONS
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

8.  Loss of Gastro-intestinal-specific Antigen in Neoplasia.

Authors:  R C Nairn; J E Fothergill; M G McEntegart; H G Richmond
Journal:  Br Med J       Date:  1962-06-30

9.  Electrophoretic and ultracentrifugal studies on the soluble proteins of various tumors and of livers from rats fed 4-dimethylaminoazobenzene.

Authors:  S SOROF; P P COHEN
Journal:  Cancer Res       Date:  1951-05       Impact factor: 12.701

10.  Antigenic differences between normal hamster kidney and stilboestrol induced kidney carcinoma: histological demonstration by means of fluorescing antibodies.

Authors:  E WEILER
Journal:  Br J Cancer       Date:  1956-09       Impact factor: 7.640

View more
  8 in total

1.  Evaluation of host immunity in human neoplasia. II. Discussion.

Authors: 
Journal:  Br J Cancer Suppl       Date:  1973-08

2.  Specific lymphocytotoxicity and blocking factors in tumours of the central nervous system.

Authors:  S Kumar; G Taylor
Journal:  Br J Cancer Suppl       Date:  1973-08

Review 3.  Immunobiologic aspects of the brain and human gliomas. A review.

Authors:  C J Wikstrand; D D Bigner
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

Review 4.  The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.

Authors:  Amy B Heimberger; John H Sampson
Journal:  Expert Opin Biol Ther       Date:  2009-08       Impact factor: 4.388

5.  Glia-specific antigen in the intracranial tumors. Immunofluorescence study.

Authors:  B Lach; H Weinrauder
Journal:  Acta Neuropathol       Date:  1978-01-19       Impact factor: 17.088

Review 6.  Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.

Authors:  John H Sampson; Gary E Archer; Duane A Mitchell; Amy B Heimberger; Darell D Bigner
Journal:  Semin Immunol       Date:  2008-06-09       Impact factor: 11.130

Review 7.  Immunotherapy of malignant brain tumors.

Authors:  Duane A Mitchell; Peter E Fecci; John H Sampson
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

8.  Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy.

Authors:  H J Bloom; M J Peckham; A E Richardson; P A Alexander; P M Payne
Journal:  Br J Cancer       Date:  1973-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.